BlackRock Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $29K | Sell |
82
-16
| -16% | -$5.66K | ﹤0.01% | 3302 |
|
|
2016
Q3 | $40K | Buy |
98
+57
| +139% | +$23.3K | ﹤0.01% | 3246 |
|
|
2016
Q2 | $24K | Buy |
41
+31
| +310% | +$18.1K | ﹤0.01% | 3349 |
|
|
2016
Q1 | $5K | Hold |
10
| – | – | ﹤0.01% | 3601 |
|
|
2015
Q4 | $7K | Hold |
10
| – | – | ﹤0.01% | 3612 |
|
|
2015
Q3 | $5K | Hold |
10
| – | – | ﹤0.01% | 3647 |
|
|
2015
Q2 | $6K | Sell |
10
-99
| -91% | -$59.4K | ﹤0.01% | 3612 |
|
|
2015
Q1 | $932K | Buy |
109
+107
| +5,350% | +$915K | ﹤0.01% | 1577 |
|
|
2014
Q4 | $18K | Buy |
+2
| New | +$18K | ﹤0.01% | 3484 |
|
|
2014
Q3 | – | Sell |
-12
| Closed | -$85K | – | 3664 |
|
|
2014
Q2 | $85K | Buy |
12
+10
| +500% | +$70.8K | ﹤0.01% | 3092 |
|
|
2014
Q1 | $11K | Buy |
+2
| New | +$11K | ﹤0.01% | 3506 |
|